Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ideaya Biosciences Inc (NQ: IDYA )

42.29 +1.40 (+3.42%)
Streaming Delayed Price Updated: 2:36 PM EDT, Jul 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 191,761
Open 41.10
Bid (Size) 42.24 (1)
Ask (Size) 42.32 (4)
Prev. Close 40.89
Today's Range 40.60 - 42.29
52wk Range 20.90 - 47.73
Shares Outstanding 48,390,394
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
MarketBeat Week in Review – 7/15 - 7/19
Stocks took a breather to close the week, but corporate earnings and the next reading on the PCE index will help determine what direction the market moves next 
Via MarketBeat
Topics Economy
Exposures Interest Rates
Positive News is Driving This Cancer Drug Maker’s Stock Higher
IDEAYA Biosciences stock is up more than 16% on positive treatment data in a Phase 2 clinical trial, but after a 76% run-up, IDYA stock may need a breather 
Via MarketBeat

Performance

YTD
+20.07%
+20.07%
1 Month
+14.33%
+14.33%
3 Month
+12.50%
+12.50%
6 Month
-0.42%
-0.42%
1 Year
+94.53%
+94.53%

More News

Read More
Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Unveiling 5 Analyst Insights On IDEAYA Biosciences
Via Benzinga
Demystifying IDEAYA Biosciences: Insights From 6 Analyst Reviews
Via Benzinga
Kura Sushi Posts Weak Q3 Results, Joins LegalZoom.com And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
Why Arhaus Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
IDEAYA Biosciences Highlights 'Encouraging' Preliminary Efficacy, Safety Profile For Patients With Hard-To-Treat Cancer
Via Benzinga
The Analyst Verdict: IDEAYA Biosciences In The Eyes Of 6 Experts
Via Benzinga
Recap: IDEAYA Biosciences Q4 Earnings
Via Benzinga
The Analyst Verdict: IDEAYA Biosciences In The Eyes Of 8 Experts
Via Benzinga
Corning Increases Sales Forecast, Joins Morphic Holding, Lucid Group And Other Big Stocks Moving Higher On Monday
Via Benzinga
Why Ideaya Biosciences Just Made Its Most Bullish Move Since March
Via Investor's Business Daily
Why Paramount Global Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Via Benzinga
IDYA Stock Earnings: IDEAYA Biosciences Misses EPS for Q1 2024
Via InvestorPlace
IDEAYA Biosciences Inc. (NASDAQ: IDYA) is a Stock Spotlight on 1/24
Via Investor Brand Network
IDEAYA Biosciences Inc. (NASDAQ: IDYA) is a Stock Spotlight on 1/19
Via Investor Brand Network
Critical Insights From IDEAYA Biosciences Analyst Ratings: What You Need To Know
Via Benzinga
Goldman Sachs Maintains Buy Rating for IDEAYA Biosciences: Here's What You Need To Know
Via Benzinga
Chart Of The Day: IDEAYA Biosciences - Oncology Biomedicine
Via Talk Markets
8 Analysts Have This to Say About IDEAYA Biosciences
Via Benzinga
The Latest Analyst Ratings for IDEAYA Biosciences
Via Benzinga
Why Ideaya Biosciences Stock Is Plummeting Today
Via The Motley Fool
Why IDEAYA Biosciences Stock Is Falling During Wednesday's Session
Via Benzinga
Why Owens Corning Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.